BioSpace News Archive

Business

TRACON to Report Third Quarter 2019 Company Highlights and Financial Results on November 5, 2019

TRACON Pharmaceuticals (NASDAQ:TCON), announced today that it will report its third quarter 2019 financial and operating results after the close of U.S. financial markets on Tuesday, November 5, 2019.

October 29, 2019
·
1 min read
Business

Theravance Biopharma to Report Third Quarter 2019 Financial Results on November 5

Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma” or the “Company”) today announced that it will release financial results for the period ended September 30, 2019 and provide a business update after market close on Tuesday, November 5, 2019.

October 29, 2019
·
2 min read
Business

Varian Names Anshul Maheshwari Vice President Investor Relations

Varian (NYSE: VAR) today announced Anshul Maheshwari, vice president and treasurer will take on an expanded role of Investor Relations effective December 1, 2019

October 29, 2019
·
1 min read
Business

TherapeuticsMD Announces Closing of Its Underwritten Public Offering of Common Stock

TherapeuticsMD, Inc. (NASDAQ:TXMD) today announced the closing of its underwritten public offering of 29,900,000 shares of its common stock at a price to the public of $2.75 per share, inclusive of the underwriters’ option to purchase additional shares of common stock, which option was exercised in full.

October 29, 2019
·
4 min read
Business

PURE Bioscience Reports Fiscal 2019 Year-End Financial Results

Update on Business Segments and PURE’s SDC-Based Antimicrobial Food Safety Solutions

October 29, 2019
·
7 min read
Business

Senseonics Holdings, Inc. Schedules Third Quarter 2019 Earnings Release and Conference Call for November 12, 2019 at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. announced that it plans to release its third quarter 2019 financial results after market close on Tuesday, November 12, 2019.

October 29, 2019
·
1 min read
Deals

Sesen Bio Strengthens Strategic and Financial Optionality

Sesen Bio, a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, reported modifications to its 2017 and 2018 common stock warrants, which enhance the Company’s capital raising optionality by allowing for future at-the-market programs.

October 29, 2019
·
4 min read
BioMidwest

Baxter to Present at the 28th Annual Credit Suisse Healthcare Conference

Baxter International Inc., a leading global medical products company, will present at the 28th Annual Credit Suisse Healthcare Conference in Scottsdale, Ariz., on November 12, 2019.

October 29, 2019
·
1 min read
Pharm Country

First Patient Dosed with Off-the-Shelf UCARTCS1 Product Candidate for Relapsed/Refractory Multiple Myeloma

Cellectis’ UCARTCS1 MELANI-01 Trial Commenced at MD Anderson Cancer Center

October 29, 2019
·
5 min read
Deals

Y-mAbs Announces Proposed Public Offering of Common Stock

Y-mAbs Therapeutics, Inc. announced the commencement of a registered underwritten public offering of up to $125 million in shares of its common stock.

October 29, 2019
·
5 min read